Global Hepatitis C Treatment Market to Reach $224.6 Billion by 2030
The global market for Hepatitis C Treatment estimated at US$97.1 Billion in the year 2022, is projected to reach a revised size of US$224.6 Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2022-2030. HCV Protease Inhibitors, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$25.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the HCV Polymerase Inhibitors segment is readjusted to a revised 10.7% CAGR for the next 8-year period.The U.S. Market is Estimated at $26.4 Billion, While China is Forecast to Grow at 14.9% CAGR
The Hepatitis C Treatment market in the U.S. is estimated at US$26.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$49.6 Billion by the year 2030 trailing a CAGR of 14.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$33.4 Billion by the year 2030.Select Competitors (Total 123 Featured) -
- AbbVie, Inc.
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG
- Gilead Sciences, Inc.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Kadmon Holdings, Inc.
- Merck & Co., Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Hepatitis C Treatment?
What is the growth rate of the Global Market for Hepatitis C Treatment?
What is the forecasted size of the Global Market for Hepatitis C Treatment?
Who are the key companies in the Global Market for Hepatitis C Treatment?
Report Attribute | Details |
---|---|
No. of Pages | 208 |
Published | March 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 97.1 Billion |
Forecasted Market Value ( USD | $ 224.6 Billion |
Compound Annual Growth Rate | 11.1% |
Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- AbbVie, Inc.
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG
- Gilead Sciences, Inc.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Kadmon Holdings, Inc.
- Merck & Co., Inc.